MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11606-019-05423-7

Медицинская библиотека · Journal of general internal medicine · 2020

Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults.

Lin Lewei Allison, Brummett Chad M, Waljee Jennifer F, Englesbe Michael J, Gunaseelan Vidhya, Bohnert Amy S B

СтатьяНаблюдательное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка правительства СШАПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

BACKGROUND

Prescribing naloxone to patients is a key strategy to prevent opioid overdoses, but little is known about the reach of naloxone prescribing.

OBJECTIVE

Determine patient factors associated with receiving naloxone and trends over time in patients with key overdose risk factors.

DESIGN

Retrospective observational study.

PARTICIPANTS

Using the Clinformatics DataMart, a US-wide health insurance claims dataset, we compared adults who received opioids and naloxone (opioid+naloxone) from January 2014 to June 2017 with adults who received opioids without naloxone (opioids only), matched on gender, age ± 5 years, month/year of opioid fill, and number of opioid claims.

MAIN MEASURES: Key patient-level opioid overdose risk factors included receipt of high-dosage opioids, concurrent benzodiazepines, history of opioid and other substance use disorders, and history of opioid overdose.

RESULTS

We included 3963 opioid+naloxone and 19,815 opioid only patients. Key factors associated with naloxone fills included high opioid daily dosage (50 to < 90 morphine milligram equivalents (MME): AOR = 2.43, 95% CI 2.15-2.76 and ≥ 90 MME: AOR = 3.94, 95% CI 3.47-4.46; reference: < 50 MME), receiving concurrent benzodiazepines (AOR = 1.27, 95% CI 1.16-1.38), and having a diagnosis of opioid use disorder (AOR = 1.56, 95% CI 1.40-1.73). History of opioid overdose was not associated with naloxone (AOR = 0.92, 95% CI 0.74-1.15). The percent of patients receiving naloxone increased, yet less than 2% of patients in any of the key overdose risk factor groups received naloxone by the last 6 months of the study period.

CONCLUSIONS

Naloxone prescribing has increased and was more likely to be co-prescribed to patients with some risk factors for overdose. However, overall prescribing remains minimal. Additional efforts are needed across health systems to increase naloxone prescribing for patients at risk for opioid overdose.

Для цитирования: Lin Lewei Allison, Brummett Chad M, Waljee Jennifer F, Englesbe Michael J, Gunaseelan Vidhya, Bohnert Amy S B. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults.. Journal of general internal medicine. 2020. DOI: 10.1007/s11606-019-05423-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.